Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment. JAMA. 2018 Apr 03; 319(13):1362-1374.
Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment.
Schiff DM, Wachman EM, Philipp B, Joseph K, Shrestha H, Taveras EM, Parker MGK
Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine
Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads. Breastfeed Med. 2018 05; 13(4):266-274.
Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads.
Wachman EM, Grossman M, Schiff DM, Philipp BL, Minear S, Hutton E, Saia K, Nikita F, Khattab A, Nolin A, Alvarez C, Barry K, Combs G, Stickney D, Driscoll J, Humphreys R, Burke J, Farrell C, Shrestha H, Whalen BL
Journal of perinatology : official journal of the California Perinatal Association
Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome. J Perinatol. 2018 08; 38(8):1114-1122.
Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome.
Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, Bharel M, Wilens TE, LaRochelle M, Walley AY, Land T
Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts. Obstet Gynecol. 2018 08; 132(2):466-474.
Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts.
Stigmatizing Language About Neonatal Abstinence Syndrome. JAMA. 2018 08 21; 320(7):722.
Stigmatizing Language About Neonatal Abstinence Syndrome.
Wachman EM, Warden AH, Thomas Z, Thomas-Lewis JA, Shrestha H, Nikita FNU, Shaw D, Saia K, Schiff DM
Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity. Drug Alcohol Depend. 2018 11 01; 192:45-50.
Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Howard MB, Wachman E, Levesque EM, Schiff DM, Kistin CJ, Parker MG
The Joys and Frustrations of Breastfeeding and Rooming-In Among Mothers With Opioid Use Disorder: A Qualitative Study. Hosp Pediatr. 2018 12; 8(12):761-768.
The Joys and Frustrations of Breastfeeding and Rooming-In Among Mothers With Opioid Use Disorder: A Qualitative Study.
Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant. Semin Fetal Neonatal Med. 2019 04; 24(2):115-120.
Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant.
Improving Treatment Engagement and Adherence to Optimize Outcomes for Opioid-Exposed Mother-Infant Dyads
Associate Professor of Psychology in the Department of Psychiatry
Conrad Taff Professor of Nutrition in the Department of Pediatrics
Lyons RM, Yule AM, Schiff D, Bagley SM, Wilens TE
Journal of child and adolescent psychopharmacology
Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature. J Child Adolesc Psychopharmacol. 2019 08; 29(7):487-497.
Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature.
Nielsen T, Bernson D, Terplan M, Wakeman SE, Yule AM, Mehta PK, Bharel M, Diop H, Taveras EM, Wilens TE, Schiff DM
Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery. Addiction. 2020 02; 115(2):291-301.
Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
Schiff DM, Nielsen T, Terplan M, Wakeman SE, Yule AM, Mehta PK, Taveras EM, Wilens TE
IMPROVING MEASURES OF DYADIC OUTCOMES IN PERINATAL SUBSTANCE USE RESEARCH. Addiction. 2020 09; 115(9):1787-1788.
IMPROVING MEASURES OF DYADIC OUTCOMES IN PERINATAL SUBSTANCE USE RESEARCH.
Winhusen T, Lofwall M, Jones HE, Wilder C, Lindblad R, Schiff DM, Wexelblatt S, Merhar S, Murphy SM, Greenfield SF, Terplan M, Wachman EM, Kropp F, Theobald J, Lewis M, Matthews AG, Guille C, Silverstein M, Rosa C
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations. Contemp Clin Trials. 2020 06; 93:106014.
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.
Schiff DM, Nielsen T, Hoeppner BB, Terplan M, Hansen H, Bernson D, Diop H, Bharel M, Krans EE, Selk S, Kelly JF, Wilens TE, Taveras EM
Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts. JAMA Netw Open. 2020 05 01; 3(5):e205734.
Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
Peeler M, Gupta M, Melvin P, Bryant AS, Diop H, Iverson R, Callaghan K, Wachman EM, Singh R, Houghton M, Greenfield SF, Schiff DM
Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother-Infant Dyads in Massachusetts (2017-2019). Am J Public Health. 2020 12; 110(12):1828-1836.
Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother-Infant Dyads in Massachusetts (2017-2019).
Harris M, Joseph K, Hoeppner B, Wachman EM, Gray JR, Saia K, Wakeman S, Bair-Merritt MH, Schiff DM
A Retrospective Cohort Study Examining the Utility of Perinatal Urine Toxicology Testing to Guide Breastfeeding Initiation. J Addict Med. 2021 Jul-Aug 01; 15(4):311-317.
A Retrospective Cohort Study Examining the Utility of Perinatal Urine Toxicology Testing to Guide Breastfeeding Initiation.
Assistant Professor of Obstetrics, Gynecology and Reproductive Biology
Bernstein SN, Peckham AM, Schiff DM, Gray JR
Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women. Obstet Gynecol. 2021 02 01; 137(2):377-378.
Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women.
Woolhandler S, Himmelstein DU, Ahmed S, Bailey Z, Bassett MT, Bird M, Bor J, Bor D, Carrasquillo O, Chowkwanyun M, Dickman SL, Fisher S, Gaffney A, Galea S, Gottfried RN, Grumbach K, Guyatt G, Hansen H, Landrigan PJ, Lighty M, McKee M, McCormick D, McGregor A, Mirza R, Morris JE, Mukherjee JS, Nestle M, Prine L, Saadi A, Schiff D, Shapiro M, Tesema L, Venkataramani A
Public policy and health in the Trump era. Lancet. 2021 02 20; 397(10275):705-753.
Public policy and health in the Trump era.
Schiff DM, Stoltman JJK, Nielsen TC, Myers S, Nolan M, Terplan M, Patrick SW, Wilens TE, Kelly J
Assessing Stigma Towards Substance Use in Pregnancy: A Randomized Study Testing the Impact of Stigmatizing Language and Type of Opioid Use on Attitudes Toward Mothers With Opioid Use Disorder. J Addict Med. 2022 Jan-Feb 01; 16(1):77-83.
Assessing Stigma Towards Substance Use in Pregnancy: A Randomized Study Testing the Impact of Stigmatizing Language and Type of Opioid Use on Attitudes Toward Mothers With Opioid Use Disorder.
Peacock-Chambers E, Schiff DM, Zuckerman B
Journal of developmental and behavioral pediatrics : JDBP
Caring for Families with Young Children Affected by Substance Use Disorder: Needed Changes. J Dev Behav Pediatr. 2021 Jun-Jul 01; 42(5):408-410.
Caring for Families with Young Children Affected by Substance Use Disorder: Needed Changes.
Schiff DM, Partridge S, Gummadi NH, Gray JR, Stulac S, Costello E, Wachman EM, Jones HE, Greenfield SF, Taveras EM, Bernstein JA
Caring for Families Impacted by Opioid Use: A Qualitative Analysis of Integrated Program Designs. Acad Pediatr. 2022 Jan-Feb; 22(1):125-136.
Caring for Families Impacted by Opioid Use: A Qualitative Analysis of Integrated Program Designs.
Schiff DM, Nielsen TC, Hoeppner BB, Terplan M, Hadland SE, Bernson D, Greenfield SF, Bernstein J, Bharel M, Reddy J, Taveras EM, Kelly JF, Wilens TE
American journal of obstetrics and gynecology
Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder. Am J Obstet Gynecol. 2021 10; 225(4):424.e1-424.e12.
Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder.
Taylor JL, Johnson S, Cruz R, Gray JR, Schiff D, Bagley SM
Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment. J Gen Intern Med. 2021 12; 36(12):3810-3819.
Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment.
A response to 'Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments'. Addiction. 2022 03; 117(3):833-834.
A response to 'Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments'.
Raffi ER, Gray J, Conteh N, Kane M, Cohen LS, Schiff DM
International review of psychiatry (Abingdon, England)
Low barrier perinatal psychiatric care for patients with substance use disorder: meeting patients across the perinatal continuum where they are. Int Rev Psychiatry. 2021 09; 33(6):543-552.
Low barrier perinatal psychiatric care for patients with substance use disorder: meeting patients across the perinatal continuum where they are.
Schiff DM, Halvorson AE, Dupont W, Davis MM, Patrick SW
Impact of stigmatizing language describing opioid-exposed mother infant dyads: A randomized case vignette study. Subst Abus. 2022; 43(1):551-555.
Impact of stigmatizing language describing opioid-exposed mother infant dyads: A randomized case vignette study.
Schiff DM, Work EC, Muftu S, Partridge S, MacMillan KDL, Gray JR, Hoeppner BB, Kelly JF, Greenfield SF, Jones HE, Wilens TE, Terplan M, Bernstein J
"You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period. J Subst Abuse Treat. 2022 08; 139:108765.
"You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period.
Koenigs KJ, Chou JH, Cohen S, Nolan M, Liu G, Terplan M, Cummings BM, Nielsen T, Smith NA, Distefano J, Bernstein SN, Schiff DM
American journal of obstetrics & gynecology MFM
Informed consent is poorly documented when obtaining toxicology testing at delivery in a Massachusetts cohort. Am J Obstet Gynecol MFM. 2022 07; 4(4):100621.
Informed consent is poorly documented when obtaining toxicology testing at delivery in a Massachusetts cohort.
Schiff DM, Work EC, Foley B, Applewhite R, Diop H, Goullaud L, Gupta M, Hoeppner BB, Peacock-Chambers E, Vilsaint CL, Bernstein JA, Bryant AS
Perinatal Opioid Use Disorder Research, Race, and Racism: A Scoping Review. Pediatrics. 2022 03 01; 149(3).
Perinatal Opioid Use Disorder Research, Race, and Racism: A Scoping Review.
Morrison TM, MacMillan KDL, Melvin P, Singh R, Murzycki J, Van Vleet MW, Rothstein R, O'Shea TF, Gupta M, Schiff DM, Wachman EM
Neonatal Opioid Withdrawal Syndrome: A Comparison of As-Needed Pharmacotherapy. Hosp Pediatr. 2022 05 01; 12(5):530-538.
Neonatal Opioid Withdrawal Syndrome: A Comparison of As-Needed Pharmacotherapy.
Increasing Awareness Is Needed Among Pediatric Hospitalists About Prenatal Substance Exposure: Policy, Advocacy, and Clinical Care. Hosp Pediatr. 2022 10 01; 12(10):e374-e376.
Increasing Awareness Is Needed Among Pediatric Hospitalists About Prenatal Substance Exposure: Policy, Advocacy, and Clinical Care.
Siegel MR, Mahowald GK, Uljon SN, James K, Leffert L, Sullivan MW, Hernandez SJ, Gray JR, Schiff DM, Bernstein SN
Fentanyl in the labor epidural impacts the results of intrapartum and postpartum maternal and neonatal toxicology tests. Am J Obstet Gynecol. 2023 06; 228(6):741.e1-741.e7.
Fentanyl in the labor epidural impacts the results of intrapartum and postpartum maternal and neonatal toxicology tests.
Cohen S, Nielsen T, Chou JH, Hoeppner B, Koenigs KJ, Bernstein SN, Smith NA, Perlman N, Sarathy L, Wilens T, Terplan M, Schiff DM
Disparities in Maternal-Infant Drug Testing, Social Work Assessment, and Custody at 5 Hospitals. Acad Pediatr. 2023 08; 23(6):1268-1275.
Disparities in Maternal-Infant Drug Testing, Social Work Assessment, and Custody at 5 Hospitals.
Sarathy L, Chou JH, Lerou PH, Terplan M, Mark K, Dorfman S, Wilens TE, Bernstein SN, Schiff DM
Limited Utility of Toxicology Testing at Delivery for Perinatal Cannabis Use. Hosp Pediatr. 2023 04 01; 13(4):317-325.
Limited Utility of Toxicology Testing at Delivery for Perinatal Cannabis Use.
Journal of child psychology and psychiatry, and allied disciplines
Expansion and commentary on a two generation approach to prenatal opioid exposure - a commentary on Conradt et al. (2023). J Child Psychol Psychiatry. 2023 04; 64(4):579-582.
Expansion and commentary on a two generation approach to prenatal opioid exposure - a commentary on Conradt et al. (2023).
Xu KY, Jones HE, Schiff DM, Martin CE, Kelly JC, Carter EB, Bierut LJ, Grucza RA
Initiation and Treatment Discontinuation of Medications for Opioid Use Disorder in Pregnant People Compared With Nonpregnant People. Obstet Gynecol. 2023 04 01; 141(4):845-853.
Initiation and Treatment Discontinuation of Medications for Opioid Use Disorder in Pregnant People Compared With Nonpregnant People.
Siegel MR, Cohen SJ, Koenigs K, Woods GT, Schwartz LN, Sarathy L, Chou JH, Terplan M, Wilens T, Ecker JL, Bernstein SN, Schiff DM
Assessing the clinical utility of toxicology testing in the peripartum period. Am J Obstet Gynecol MFM. 2023 07; 5(7):100963.
Assessing the clinical utility of toxicology testing in the peripartum period.
Standish KR, Morrison TM, Wanar A, Crowell L, Safon CB, Colson E, Drainoni ML, Colvin BN, Friedman H, Schiff DM, Stulac S, Costello E, Parker M
Breastfeeding Decision-Making Among Mothers with Opioid Use Disorder: A Qualitative Study. Breastfeed Med. 2023 05; 18(5):347-355.
Breastfeeding Decision-Making Among Mothers with Opioid Use Disorder: A Qualitative Study.
The White House's Strategic Plan to Address the Opioid Crisis. JAMA. 2023 06 27; 329(24):2194-2195.
The White House's Strategic Plan to Address the Opioid Crisis.
Work EC, Muftu S, MacMillan KDL, Gray JR, Bell N, Terplan M, Jones HE, Reddy J, Wilens TE, Greenfield SF, Bernstein J, Schiff DM
Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder. Matern Child Health J. 2023 Dec; 27(Suppl 1):104-112.
Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder.
Morrison TM, Standish KR, Wanar A, Crowell L, Safon CB, Colvin BN, Friedman H, Schiff DM, Wachman EM, Colson ER, Drainoni ML, Parker MG
Drivers of decision-making regarding infant sleep practices among mothers with opioid use disorder. J Perinatol. 2023 07; 43(7):923-929.
Drivers of decision-making regarding infant sleep practices among mothers with opioid use disorder.
Wanar A, Morrison TM, Standish KR, Colson ER, Drainoni ML, Colvin BN, Safon CB, Crowell L, Friedman H, Schiff DM, Parker MG
Journal of substance use and addiction treatment
Understanding cigarette smoking among mothers with opioid use disorder. J Subst Use Addict Treat. 2023 07; 150:209065.
Understanding cigarette smoking among mothers with opioid use disorder.
Xu KY, Schiff DM, Jones HE, Martin CE, Kelly JC, Bierut LJ, Carter EB, Grucza RA
Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA. J Gen Intern Med. 2023 12; 38(16):3499-3508.
Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA.
Osei-Poku GK, Prentice JC, Peeler M, Bernstein SN, Iverson RE, Schiff DM
Women's health issues : official publication of the Jacobs Institute of Women's Health
Risk of Severe Maternal Morbidity in Birthing People With Opioid Use Disorder. Womens Health Issues. 2023 Sep-Oct; 33(5):524-531.
Risk of Severe Maternal Morbidity in Birthing People With Opioid Use Disorder.
Sternberger L, Sorensen-Alawad A, Prescott T, Sakai H, Brown K, Finkelstein N, Salomon A, Schiff DM
Lessons Learned Serving Pregnant, Postpartum, and Parenting People with Substance Use Disorders in Massachusetts: The Moms Do Care Program. Matern Child Health J. 2023 Dec; 27(Suppl 1):67-74.
Lessons Learned Serving Pregnant, Postpartum, and Parenting People with Substance Use Disorders in Massachusetts: The Moms Do Care Program.
Harris M, Schiff DM, Saia K, Muftu S, Standish KR, Wachman EM
Academy of Breastfeeding Medicine Clinical Protocol #21: Breastfeeding in the Setting of Substance Use and Substance Use Disorder (Revised 2023). Breastfeed Med. 2023 10; 18(10):715-733.
Academy of Breastfeeding Medicine Clinical Protocol #21: Breastfeeding in the Setting of Substance Use and Substance Use Disorder (Revised 2023).
Schiff DM, Muftu S, MacMillan KDL, Work EC, Hoeppner BB, Greenfield SF, Schwartz L, Chaiyachati B, Wilens TE, Bernstein JA
Mutual Mistrust: The Multilayered Experiences at the Intersection of Healthcare and Early Parenting Among Mothers With Opioid Use Disorder. J Addict Med. 2024 Jan-Feb 01; 18(1):55-61.
Mutual Mistrust: The Multilayered Experiences at the Intersection of Healthcare and Early Parenting Among Mothers With Opioid Use Disorder.
Morrison TM, Schiff DM, Olson A, Hunter RG, Agarwal J, Work EC, Muftu S, Shrestha H, Boateng J, Werler MM, Carter G, Jones HE, Wachman EM
Hair Cortisol Concentrations in Opioid-Exposed versus Nonexposed Mother-Infant Dyads. Am J Perinatol. 2024 06; 41(8):1106-1112.
Hair Cortisol Concentrations in Opioid-Exposed versus Nonexposed Mother-Infant Dyads.
Mascarenhas M, Wachman EM, Chandra I, Xue R, Sarathy L, Schiff DM
Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2024 Jan 01; 153(2).
Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome.
Prenatal Opioid Use Disorder Treatment-the Importance of Shared Decision-Making. JAMA Intern Med. 2024 Mar 01; 184(3):252-253.
Prenatal Opioid Use Disorder Treatment-the Importance of Shared Decision-Making.
Opioids in Hospitalized Infants-Managing Pain and Sedation While Avoiding Overuse. JAMA Netw Open. 2024 03 04; 7(3):e240523.
Opioids in Hospitalized Infants-Managing Pain and Sedation While Avoiding Overuse.
Singh R, Melvin P, Wachman EM, Rothstein R, Schiff DM, Murzycki J, VanVleet M, Gupta M, Davis JM
Short term outcomes of neonatal opioid withdrawal syndrome: a comparison of two approaches. J Perinatol. 2024 Aug; 44(8):1137-1145.
Short term outcomes of neonatal opioid withdrawal syndrome: a comparison of two approaches.
Khazanchi R, Wachman EM, Schiff DM, Modest A, Saia KA, Hsu HE
Mandatory Child Protective Services Reporting for Substance-Exposed Newborns and Peripartum Outcomes: A Difference-in-Differences Analysis. JAMA Pediatr. 2024 Jul 01; 178(7):719-722.
Mandatory Child Protective Services Reporting for Substance-Exposed Newborns and Peripartum Outcomes: A Difference-in-Differences Analysis.
Reddy J, Schiff D, Terplan M, Jones H, Putnam-Hornstein E
Child Protection System Removal and Short-Interval Births Among Individuals With Prenatal Substance Use. Obstet Gynecol. 2024 05 01; 143(5):700-703.
Child Protection System Removal and Short-Interval Births Among Individuals With Prenatal Substance Use.
Schiff DM, Li WZM, Work EC, Goullaud L, Vazquez J, Paulet T, Dorfman S, Selk S, Hoeppner BB, Wilens T, Bernstein JA, Diop H
Multiple marginalized identities: A qualitative exploration of intersectional perinatal experiences of birthing people of color with substance use disorder in Massachusetts. J Subst Use Addict Treat. 2024 Aug; 163:209346.
Multiple marginalized identities: A qualitative exploration of intersectional perinatal experiences of birthing people of color with substance use disorder in Massachusetts.
Nidey N, Gerdts G, Kavouras M, Schiff DM
Addressing stigma for families affected by opioid use disorder. Semin Perinatol. 2025 Feb; 49(1):152018.
Addressing stigma for families affected by opioid use disorder.
Schiff DM, Walt G, Kane M, Maitland M, Liu G, Wakeman SE, Gray, JR
Development of a Clinical Decision-Making Framework to Address Parental Substance Use and Child Safety. Parenting. 2024; 1-21.
Development of a Clinical Decision-Making Framework to Address Parental Substance Use and Child Safety
Rohde JF, Chaiyachati BH, Demharter NS, Dorrian C, Gregory EF, Hossain J, McAllister JM, Ratner JA, Schiff DM, Shedlock AR, Sibinga EMS, Goyal NK
Pediatric Primary Care of Children With Intrauterine Opioid Exposure: Survey of Academic Teaching Practices. Acad Pediatr. 2024 Nov-Dec; 24(8):1304-1313.
Pediatric Primary Care of Children With Intrauterine Opioid Exposure: Survey of Academic Teaching Practices.
Addressing Drivers of Sudden Unexplained Infant Death Among Prenatally Substance-Exposed Infants. Pediatrics. 2024 Dec 01; 154(6).
Addressing Drivers of Sudden Unexplained Infant Death Among Prenatally Substance-Exposed Infants.
Dosing Inequities in Opioid Use Disorder Treatment Trials. JAMA Netw Open. 2024 10 01; 7(10):e2436582.
Dosing Inequities in Opioid Use Disorder Treatment Trials.
Liu G, Wright BJ, Schwartz LN, Yeo EJ, Bernstein SN, Ostfeld-Johns S, Schiff DM
"Like a Hot Potato": Breakdown of Clinician-Parent Communication About Newborn Toxicology Testing. Hosp Pediatr. 2025 Apr 01; 15(4):334-341.
"Like a Hot Potato": Breakdown of Clinician-Parent Communication About Newborn Toxicology Testing.
Reddy J, Halpern CT, Schiff DM, Jones H, Austin A, Faherty L, Rebbe R, Vines A, Putnam-Hornstein E
Prenatal Substance Exposure and Multilevel Predictors of Child Protection System Reporting. J Pediatr. 2025 07; 282:114546.
Prenatal Substance Exposure and Multilevel Predictors of Child Protection System Reporting.
Parker MG, Rice F, Peguero C, Evans A, Schiff DM, Colvin B, Friedman H, Harer K, Kerr SM, Corwin MJ, Heeren TC, Colson ER, Wachman EM
Use of Practices to Reduce of Sudden Unexpected Infant Death Among Caregivers of Opioid Exposed Newborns. J Addict Med. 2025 Jul-Aug 01; 19(4):418-422.
Use of Practices to Reduce of Sudden Unexpected Infant Death Among Caregivers of Opioid Exposed Newborns.
Gerdts G, Sale K, Raynor P, Schiff DM, Terplan M, Bush E, Nidey N
Racial and Ethnic Inequities in the Receipt of Medications to Treat Opioid Use Disorder Among Pregnant People: A Meta-analysis. J Addict Med. 2025 Jul-Aug 01; 19(4):437-445.
Racial and Ethnic Inequities in the Receipt of Medications to Treat Opioid Use Disorder Among Pregnant People: A Meta-analysis.
Ratner JA, Chaiyachati BH, Demharter NS, Gannon M, Hossain J, Larkin O, McAllister JM, Peera F, Schiff DM, Sibinga EMS, Rohde JF, Goyal NK
Pediatricians' Attitudes Toward and Use of Terminology About Mothers With Opioid Use Disorder. J Addict Med. 2025 Nov-Dec 01; 19(6):646-654.
Pediatricians' Attitudes Toward and Use of Terminology About Mothers With Opioid Use Disorder.
Reimagining "Plans of Safe Care:" Promoting Recovery, Family Well-being, and Engendering Trust through Family Care Planning
Howard MB, Schiff DM, Penwill N, Si W, Rai A, Wolfgang T, Moses JM, Wachman EM
Impact of Parental Presence at Infants' Bedside on Neonatal Abstinence Syndrome. Hosp Pediatr. 2017 02; 7(2):63-69.
Impact of Parental Presence at Infants' Bedside on Neonatal Abstinence Syndrome.
Abdou R, Romm I, Schiff D, Austad K, Dubal S, Kimmel S, Schiff E
In solidarity with Gaza. Lancet. 2009 Jan 24; 373(9660):295.
Brugge D, Hong JS, Schiff D, Hui C, Moy S, Palella M, Buchner V, Woodin M
Methodological lessons and pilot data on the effect of proximity of homes and schools to highways on pediatric asthma and lung function. Rev Environ Health. 2011; 26(2):119-25.
Methodological lessons and pilot data on the effect of proximity of homes and schools to highways on pediatric asthma and lung function.
Saia KA, Schiff D, Wachman EM, Mehta P, Vilkins A, Sia M, Price J, Samura T, DeAngelis J, Jackson CV, Emmer SF, Shaw D, Bagley S
Current obstetrics and gynecology reports
Caring for Pregnant Women with Opioid Use Disorder in the USA: Expanding and Improving Treatment. Curr Obstet Gynecol Rep. 2016; 5:257-263.
Caring for Pregnant Women with Opioid Use Disorder in the USA: Expanding and Improving Treatment.
Treatment of Opioid Use Disorder During Pregnancy and Cases of Neonatal Abstinence Syndrome. JAMA Pediatr. 2017 07 01; 171(7):707.
Treatment of Opioid Use Disorder During Pregnancy and Cases of Neonatal Abstinence Syndrome.
Bringing attention to a need for a standardized treatment and weaning protocol for neonatal abstinence syndrome. Transl Pediatr. 2016 Jan; 5(1):12-5.
Bringing attention to a need for a standardized treatment and weaning protocol for neonatal abstinence syndrome.
A Public Health Response to Opioid Use in Pregnancy. Pediatrics. 2017 Mar; 139(3).
A Public Health Response to Opioid Use in Pregnancy.
Addiction Treatment Referral through Local Police. N Engl J Med. 2017 03 09; 376(10):999.
Addiction Treatment Referral through Local Police.
Schiff DM, Drainoni ML, Bair-Merritt M, Weinstein Z, Rosenbloom D
A Police-Led Addiction Treatment Referral Program in Massachusetts. N Engl J Med. 2016 12 22; 375(25):2502-2503.
A Police-Led Addiction Treatment Referral Program in Massachusetts.
Schiff DM, Zuckerman B, Wachman EM, Bair-Merritt M
Trainees' knowledge, attitudes, and practices towards caring for the substance-exposed mother-infant dyad. Subst Abus. 2017 Oct-Dec; 38(4):414-421.
Trainees' knowledge, attitudes, and practices towards caring for the substance-exposed mother-infant dyad.
Schiff DM, Zuckerman B, Hutton E, Genatossio C, Michelson C, Bair-Merritt M
Development and Pilot Implementation of a Trauma-Informed Care Curriculum for Pediatric Residents. Acad Pediatr. 2017 Sep - Oct; 17(7):794-796.
Development and Pilot Implementation of a Trauma-Informed Care Curriculum for Pediatric Residents.
Schiff DM, Drainoni ML, Weinstein ZM, Chan L, Bair-Merritt M, Rosenbloom D
A police-led addiction treatment referral program in Gloucester, MA: Implementation and participants' experiences. J Subst Abuse Treat. 2017 11; 82:41-47.
A police-led addiction treatment referral program in Gloucester, MA: Implementation and participants' experiences.
Maternal Health in the United States. N Engl J Med. 2018 02 08; 378(6):587.